| No. of Positive/No. of Total | Prevalence (95% CI) | Adjusted OR a,b (95% CI) |
---|---|---|---|
Past infection | Â | Â | Â |
Anti-TOX IgG+/IgM- | Â | Â | Â |
All migrants | 15,042/443,725 | 3.39 (3.34–3.44) | 0.89 (0.88–0.91) |
Intra-provincial | 7954/229,001 | 3.47 (3.40–3.55) | 0.96 (0.94–0.99) |
Inter-provincial | 7088/214,724 | 3.30 (3.23–3.38) | 0.82 (0.80–0.85) |
Native spouse | 8863/286,590 | 3.09 (3.03–3.16) | 0.91 (0.89–0.94) |
Migrant spouse | 6166/156,855 | 3.93 (3.84–4.03) | 0.86 (0.84–0.89) |
Natives | 62,201/2,007,572 | 3.10 (3.07–3.12) | Reference |
Anti-CMV IgG+/IgM- | Â | Â | Â |
All migrants | 379,277/443,725 | 85.48 (85.38–85.57) | 1.26 (1.25–1.28) |
Intra-provincial | 191,238/229,001 | 83.51 (83.36–83.66) | 1.21 (1.19–1.23) |
Inter-provincial | 188,039/214,724 | 87.57 (87.43–87.71) | 1.37 (1.35–1.39) |
Native spouse | 230,556/286,590 | 80.45 (80.32–80.58) | 1.09 (1.08–1.10) |
Migrant spouse | 148,455/156,855 | 94.64 (94.53–94.76) | 2.49 (2.43–2.56) |
Natives | 1,514,434/2,007,572 | 75.44 (75.38–75.49) | Reference |
Recent infection | Â | Â | Â |
Anti-TOX IgM+/(IgG- or IgG+) | Â | Â | Â |
All migrants | 2114/443,725 | 0.48 (0.46–0.50) | 1.88 (1.77–1.99) |
Intra-provincial | 849/229,001 | 0.37 (0.35–0.40) | 1.57 (1.45–1.70) |
Inter-provincial | 1265/214,724 | 0.59 (0.56–0.62) | 2.23 (2.08–2.39) |
Native spouse | 832/286,590 | 0.29 (0.27–0.31) | 1.25 (1.16–1.36) |
Migrant spouse | 1279/156,855 | 0.82 (0.77–0.86) | 2.99 (2.77–3.22) |
Natives | 4383/2,007,572 | 0.22 (0.21–0.22) | Reference |
Anti-CMV IgM+/(IgG- or IgG+) | Â | Â | Â |
All migrants | 1687/443,725 | 0.38 (0.36–0.40) | 0.96 (0.91–1.02) |
Intra-provincial | 870/229,001 | 0.38 (0.36–0.41) | 0.99 (0.92–1.07) |
Inter-provincial | 817/214,724 | 0.38 (0.35–0.41) | 0.93 (0.86–1.01) |
Native spouse | 1051/286,590 | 0.37 (0.34–0.39) | 0.99 (0.92–1.07) |
Migrant spouse | 636/156,855 | 0.41 (0.37–0.44) | 0.91 (0.82–0.99) |
Natives | 7008/2,007,572 | 0.35 (0.34–0.36) | Reference |